Compare United Parcel Service Inc (UPS) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United Parcel Service Inc vs Viatris Inc — how do they compare? United Parcel Service Inc trades at $104.63 (market cap $88.85B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: United Parcel Service Inc is far larger — about 4.8× Viatris Inc's market cap, and United Parcel Service Inc pays the higher dividend (6.28%). Which is the better fit depends on your goals.
| UPS | VTRS | |
|---|---|---|
Market Cap | $88.85B | $18.69B |
Volume | 2,288,643 | — |
Sector | Industrials | Health |
52-Week High | $120.00 | $17.86 |
52-Week Low | $82.58 | $9.49 |
Enterprise Value | $112.87B | $30.80B |
Dividend Yield | 6.28% | 2.95% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
